BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 15267206)

  • 1. [Combined therapy for the chronic pelvic pain syndrome].
    Xu S; Qi G; Tang P; Li Y
    Zhonghua Nan Ke Xue; 2004 Jun; 10(6):429-30, 433. PubMed ID: 15267206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Retrospective analysis of the combined therapy of terazosin with chlormezanone for chronic prostatitis/chronic pelvic pain syndrome].
    Yan S; Li HZ; Zhang XY; Li HJ
    Zhonghua Nan Ke Xue; 2009 Aug; 15(8):717-20. PubMed ID: 19852273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT.
    Shoskes DA; Nickel JC; Kattan MW
    Urology; 2010 Jun; 75(6):1249-53. PubMed ID: 20363491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of alpha1 adrenoceptor antagonist, naftopidil, on non-bacterial chronic pelvic pain syndrome in patients with lower urinary tract syndrome: evaluation of its efficacy using NIH-CPSI after 4-week treatment].
    Suzuki A; Ohinata M; Fujishima M; Hirano S; Kudou T; Funaki H; Akasaka T
    Hinyokika Kiyo; 2010 Apr; 56(4):215-9. PubMed ID: 20448445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-nanobacterial therapy for men with chronic prostatitis/chronic pelvic pain syndrome and prostatic stones: preliminary experience.
    Shoskes DA; Thomas KD; Gomez E
    J Urol; 2005 Feb; 173(2):474-7. PubMed ID: 15643213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preliminary experience in treatment of chronic prostatitis/chronic pelvic pain syndrome with Longjintonglin capsule].
    Shang XJ; Huang YF; Shao Y; Xue XT; Guan FG; Li G; Wang J
    Zhonghua Nan Ke Xue; 2006 Apr; 12(4):371-3. PubMed ID: 16683576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of a monotherapy strategy for difficult chronic prostatitis/chronic pelvic pain syndrome.
    Nickel JC; Downey J; Ardern D; Clark J; Nickel K
    J Urol; 2004 Aug; 172(2):551-4. PubMed ID: 15247727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo controlled trial.
    Cheah PY; Liong ML; Yuen KH; Teh CL; Khor T; Yang JR; Yap HW; Krieger JN
    J Urol; 2003 Feb; 169(2):592-6. PubMed ID: 12544314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoxetine ameliorates symptoms of refractory chronic prostatitis/chronic pelvic pain syndrome.
    Xia D; Wang P; Chen J; Wang S; Jiang H
    Chin Med J (Engl); 2011 Jul; 124(14):2158-61. PubMed ID: 21933619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The efficacy and safety in the treatment of chronic abacterial prostatitis/chronic pelvic pain syndrome after intraprostatic injection of Chuanshentong].
    Liu ZT; Liao HQ; Yang JY; Yang LY; Yang JR; Zhao XK; Liu R
    Zhonghua Nan Ke Xue; 2005 Sep; 11(9):705-7. PubMed ID: 16209215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of alpha1-blockers in chronic prostatitis syndromes.
    Nickel JC
    BJU Int; 2008 Mar; 101 Suppl 3():11-6. PubMed ID: 18307680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of alpha-adrenergic antagonists in chronic prostatitis/chronic pelvic pain syndrome: a meta-analysis of randomized controlled trials.
    Yang G; Wei Q; Li H; Yang Y; Zhang S; Dong Q
    J Androl; 2006; 27(6):847-52. PubMed ID: 16870951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective, randomized, double-blind trial to evaluate the role of a short reducing course of oral corticosteroid therapy in the treatment of chronic prostatitis/chronic pelvic pain syndrome.
    Bates SM; Hill VA; Anderson JB; Chapple CR; Spence R; Ryan C; Talbot MD
    BJU Int; 2007 Feb; 99(2):355-9. PubMed ID: 17313424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. More effects of extracorporeal magnetic innervation and terazosin therapy than terazosin therapy alone for non-inflammatory chronic pelvic pain syndrome: a pilot study.
    Paick JS; Lee SC; Ku JH
    Prostate Cancer Prostatic Dis; 2006; 9(3):261-5. PubMed ID: 16683008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment for chronic prostatitis/chronic pelvic pain syndrome: levofloxacin, doxazosin and their combination.
    Jeong CW; Lim DJ; Son H; Lee SE; Jeong H
    Urol Int; 2008; 80(2):157-61. PubMed ID: 18362485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of patient response to antibiotic therapy for the chronic prostatitis/chronic pelvic pain syndrome: a prospective multicenter clinical trial.
    Nickel JC; Downey J; Johnston B; Clark J;
    J Urol; 2001 May; 165(5):1539-44. PubMed ID: 11342913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect and mechanism of alpha1-adrenoceptor blocker combined with antibiotics for chronic prostatitis].
    Shen B; Jin X; Cai S; Chen J; Chen G; Zhao W; Sun X
    Zhonghua Nan Ke Xue; 2004 Jul; 10(7):518-20. PubMed ID: 15354524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial.
    Nickel JC; Narayan P; McKay J; Doyle C
    J Urol; 2004 Apr; 171(4):1594-7. PubMed ID: 15017228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-year experience with the german-translated version of the NIH-CPSI in patients with CP/CPPS.
    Schneider H; Brähler E; Ludwig M; Hochreiter W; Collins MF; Eremenco S; Weidner W
    Urology; 2004 Jun; 63(6):1027-30. PubMed ID: 15183940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of chronic prostatitis/chronic pelvic pain syndrome category IIIA with Serenoa repens plus selenium and lycopene (Profluss) versus S. repens alone: an Italian randomized multicenter-controlled study.
    Morgia G; Mucciardi G; Galì A; Madonia M; Marchese F; Di Benedetto A; Romano G; Bonvissuto G; Castelli T; Macchione L; Magno C
    Urol Int; 2010; 84(4):400-6. PubMed ID: 20332612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.